RA-risk cohort, n = 100 | SpA-risk cohort, n = 38 | |
---|---|---|
Age, mean (SD) | 54 (11) | 28 (7) |
Female sex, n (%) | 71 (71) | 25 (66) |
Current smoker, n (%) | 17 (17) | 8 (21) |
VAS joint pain, median (IQR) | 24 (5–50) | – |
Self-reported history of swollen joints (median, IQR) | 0 (0–0) | – |
RF positive, n (%) | 72 (72) | – |
ACPA positive, n (%) | 37 (37) | – |
High RA-risk (≥ 38% in 4 years)*, n (%) | 40 | - |
Back pain present, n (%) | – | 28 (74) |
Inflammatory back pain present, n (%) | – | 6 (21) |
VAS back pain, median (IQR) | - | 14 (0–36) |
HLA-B27 positive, n (%) | – | 20 (56) |